Biotechnology Assets S.A. Cash Flow-to-Debt Ratio
Biotechnology Assets S.A. cash flow-to-debt ratio. Biotechnology Assets S.A. (BST) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2025, meaning its operating cash flow of €658.13K could theoretically repay 0% of its total liabilities (€7.01 Million) in one year. Check BST cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biotechnology Assets S.A. (2014–2024)
Cash flow-to-debt ratio of Biotechnology Assets S.A. from 2014 to 2024. Historical debt coverage capacity for Biotechnology Assets S.A. across 11 annual periods. Check Biotechnology Assets S.A. (BST) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Biotechnology Assets S.A. Cash Flow-to-Debt Ratio by Year (2014–2024)
Biotechnology Assets S.A. cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Biotechnology Assets S.A.. For the full cash flow conversion analysis, see Biotechnology Assets S.A. cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-73.85K | €8.17 Million | ▼ -290.7% |
| 2023 | 0.00x | €47.74K | €10.08 Million | ▲ +104.0% |
| 2022 | -0.12x | €-1.73 Million | €14.60 Million | ▼ -22.8% |
| 2021 | -0.10x | €-1.50 Million | €15.54 Million | ▼ -118.0% |
| 2020 | 0.54x | €8.79 Million | €16.37 Million | ▲ +401.6% |
| 2019 | -0.18x | €-15.16 Million | €85.11 Million | ▲ +20.6% |
| 2018 | -0.22x | €-13.02 Million | €58.04 Million | ▼ -1104.4% |
| 2017 | 0.02x | €213.49K | €9.56 Million | ▼ -93.4% |
| 2016 | 0.34x | €2.71 Million | €8.02 Million | ▲ +1447.8% |
| 2015 | 0.02x | €158.16K | €7.23 Million | ▲ +150.5% |
| 2014 | -0.04x | €-303.79K | €7.01 Million | — |